149 related articles for article (PubMed ID: 33788733)
21. Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
Huang X; Lan Y; Li E; Li J; Deng Q; Deng X
J Int Med Res; 2021 May; 49(5):3000605211012570. PubMed ID: 33942633
[TBL] [Abstract][Full Text] [Related]
22. The role of RCAS1 as a biomarker in diagnosing CRC and monitoring tumor recurrence and metastasis.
Han SX; Wang J; Wang LJ; Jin GH; Ying X; He CC; Guo XJ; Zhang JY; Zhang Y; Zhu Q
Tumour Biol; 2014 Jun; 35(6):6149-57. PubMed ID: 24652591
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.
Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P
Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121
[TBL] [Abstract][Full Text] [Related]
24. The role of carcinoembryonic antigen as an assessment tool for predicting disease severity among patients with colorectal cancer in resource-poor setting of Kwazulu-Natal, South Africa.
Naicker YD; Moolla Z; Madiba T
Pan Afr Med J; 2021; 39():185. PubMed ID: 34584610
[TBL] [Abstract][Full Text] [Related]
25. Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer.
Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B
Dig Dis Sci; 2005 Jun; 50(6):1019-24. PubMed ID: 15986847
[TBL] [Abstract][Full Text] [Related]
26. Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer.
Dong D; Zhang L; Jia L; Ji W; Wang Z; Ren L; Niu R; Zhou Y
Clin Lab; 2018 Jun; 64(6):973-981. PubMed ID: 29945311
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of the combined measurement of serum B7-H1 and interleukin-10 in colorectal cancer patients.
Wang P; Li C; Ma X; Gai X
Medicine (Baltimore); 2020 May; 99(18):e20044. PubMed ID: 32358386
[TBL] [Abstract][Full Text] [Related]
28. Altered Serum Annexin A2 Might Be a New Potential Diagnostic Biomarker in Human Colorectal Cancer.
Hu D; Shen B; Yu M; Zha X; Zhou Y; Chen F; Ren J; Zhang L
Ann Clin Lab Sci; 2020 Nov; 50(6):726-733. PubMed ID: 33334786
[TBL] [Abstract][Full Text] [Related]
29. Soluble intercellular adhesion molecule-1 is a prognostic marker in colorectal carcinoma.
Schellerer VS; Langheinrich MC; Zver V; Grützmann R; Stürzl M; Gefeller O; Naschberger E; Merkel S
Int J Colorectal Dis; 2019 Feb; 34(2):309-317. PubMed ID: 30470940
[TBL] [Abstract][Full Text] [Related]
30. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
31. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
[TBL] [Abstract][Full Text] [Related]
32. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
33. Plasma heat shock protein 90-alpha have an advantage in diagnosis of colorectal cancer at early stage.
Kasanga M; Liu L; Xue L; Song X
Biomark Med; 2018 Aug; 12(8):881-890. PubMed ID: 29939072
[TBL] [Abstract][Full Text] [Related]
34. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
[TBL] [Abstract][Full Text] [Related]
35. Carcinoembryonic Antigen (CEA) and Hepatic Metastasis in Colorectal Cancer: Update on Biomarker for Clinical and Biotechnological Approaches.
Campos-da-Paz M; Dórea JG; Galdino AS; Lacava ZGM; de Fatima Menezes Almeida Santos M
Recent Pat Biotechnol; 2018; 12(4):269-279. PubMed ID: 30062978
[TBL] [Abstract][Full Text] [Related]
36. Combined analysis of survivin autoantibody and carcinoembryonic antigen biomarkers for improved detection of colorectal cancer.
Chen JS; Chen KT; Fan WC; Yu JS; Chang YS; Chan EC
Clin Chem Lab Med; 2010 May; 48(5):719-25. PubMed ID: 20178447
[TBL] [Abstract][Full Text] [Related]
37. Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer.
Ostendorff HP; Awad A; Braunschweiger KI; Liu Z; Wan Z; Rothschild KJ; Lim MJ
J Immunol Methods; 2013 Dec; 400-401():58-69. PubMed ID: 24161315
[TBL] [Abstract][Full Text] [Related]
38. [Expression and significance of serum microRNA-135a-5p level in colorectal cancer].
Wang QJ; Zhang HC; Shen XJ; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):909-914. PubMed ID: 27998467
[No Abstract] [Full Text] [Related]
39. Diagnostic value of carcinoembryonic antigen combined with cytokines in serum of patients with colorectal cancer.
Ma Y; Zhang Y; Bi Y; He L; Li D; Wang D; Wang M; Wang X
Medicine (Baltimore); 2022 Sep; 101(37):e30787. PubMed ID: 36123861
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
Wang YR; Yan JX; Wang LN
J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]